BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10831356)

  • 1. p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma.
    Schmitz MJ; Hendricks DT; Farley J; Taylor RR; Geradts J; Rose GS; Birrer MJ
    Gynecol Oncol; 2000 Jun; 77(3):439-45. PubMed ID: 10831356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
    Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P
    Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel.
    Arber N; Hibshoosh H; Yasui W; Neugut AI; Hibshoosh A; Yao Y; Sgambato A; Yamamoto H; Shapira I; Rosenman D; Fabian I; Weinstein IB; Tahara E; Holt PR
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1101-5. PubMed ID: 10613343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
    Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
    Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-EspaƱa A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations].
    Liu JH; Huang H; Huang X; Zeng MS; Li W
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):312-6. PubMed ID: 16677523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of adenocarcinoma of the cervix.
    Parker MF; Arroyo GF; Geradts J; Sabichi AL; Park RC; Taylor RR; Birrer MJ
    Gynecol Oncol; 1997 Feb; 64(2):242-51. PubMed ID: 9038270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
    Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
    Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
    Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
    Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma.
    Baba Y; Tsukuda M; Mochimatsu I; Furukawa S; Kagata H; Satake K; Koshika S; Nakatani Y; Hara M; Kato Y; Nagashima Y
    Cancer Detect Prev; 2001; 25(5):414-9. PubMed ID: 11718447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes.
    Zheng W; Cao P; Zheng M; Kramer EE; Godwin TA
    Gynecol Oncol; 1996 May; 61(2):167-74. PubMed ID: 8626128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma.
    Hui AM; Li X; Shi YZ; Takayama T; Torzilli G; Makuuchi M
    Clin Cancer Res; 2000 Nov; 6(11):4272-7. PubMed ID: 11106243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
    Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
    Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.